Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Aminouracil is a synthetic pyrimidone derivative and structural analog of uracil. It is classified as a thymine antagonist and acts primarily as an inhibitor of DNA replication. In experimental settings—particularly in plant cell biology—it has been used to induce DNA replication stress by interfering with the S-phase checkpoint mechanisms. This results in altered cell cycle progression and can lead to premature chromosome condensation or abnormal nuclear organization. Its main utility has been as a research tool for studying DNA synthesis and cell cycle regulation rather than as a therapeutic agent[1][8]. There are no approved medical indications or clinical uses for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-aminouracil.